Also trades as: DRREDDY.NS (NSE) · $vol 25M · DRREDDY.BO (BSE) · $vol 1M
RDY NYSE
Dr. Reddy's Laboratories Limited
1W: +0.1%
1M: +0.7%
3M: -14.6%
YTD: -11.5%
1Y: -13.7%
3Y: -5.8%
5Y: -3.4%
$12.25
+0.00 (+0.00%)
Weekly Expected Move ±4.2%
$11
$12
$12
$13
$13
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$56.6B
+22.0% ▲
5Y CAGR: +9.7%
Capital Expenditures
$24.5B
+28.6% ▲
5Y CAGR: +14.3%
Free Cash Flow
$32.1B
+166.8% ▲
5Y CAGR: +6.8%
Dividends Paid
$7.0B
-5.2% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$876M
-111.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $23.6B | $45.1B | $55.7B | $57.2B | $45.1B |
| Depreciation & Amort. | $11.8B | $12.6B | $14.8B | $17.1B | $21.7B |
| Stock-Based Comp. | $592M | $397M | $407M | $424M | $0 |
| Change in Working Capital | -$13.9B | -$7.9B | -$20.2B | -$30.0B | -$12.2B |
| Other Non-Cash Items | -$2.7B | -$6.7B | -$21.5B | -$17.8B | $2.1B |
| Operating Cash Flow | $28.1B | $58.9B | $45.4B | $46.4B | $56.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$19.0B | -$11.3B | -$16.4B | -$27.5B | -$40.4B |
| Acquisitions (Net) | -$326M | $0 | -$12M | -$53.4B | -$3.0B |
| Investment Purchases | -$89.0B | -$136.2B | -$145.5B | -$254.5B | -$49.2B |
| Investment Sales | $77.8B | $112.8B | $129.8B | $279.6B | $20.6B |
| Other Investing | $4.2B | -$6.7B | -$8.2B | -$2.3B | $1.5B |
| Investing Cash Flow | -$26.4B | -$41.4B | -$40.3B | -$58.1B | -$70.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | $2.7B | -$20.4B | $4.3B | $23.2B | $21.3B |
| Stock Repurchased | $0 | $0 | $0 | -$1.4B | $0 |
| Dividends Paid | -$4.1B | -$5.0B | -$6.6B | -$6.7B | -$7.0B |
| Other Financing | -$1.3B | -$1.9B | -$2.3B | $3.6B | -$1.3B |
| Financing Cash Flow | -$2.4B | -$26.9B | -$3.8B | $18.9B | $13.4B |
| Net Change in Cash | $32M | -$9.1B | $1.3B | $7.5B | -$876M |
| Cash End of Period | $14.9B | $5.8B | $7.1B | $14.6B | $15.1B |
| Free Cash Flow | $9.1B | $40.0B | $18.0B | $12.0B | $32.1B |